M33 Growth I L.P. bought TOI

November 18, 2025 · Form 4 insider transaction

M33 Growth I L.P. bought 11,818 shares of Starling Oncology Inc, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
11,818
Price
N/A
Total value
N/A
Role
SecurityCommon Stock
Transaction codeJ: J
Transaction dateNovember 18, 2025
Filing dateNovember 20, 2025
Shares owned after7,944,207
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. ("M33 LP"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners.; M33 Growth I GP LLC is the general partner of M33 LP and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.

View the original Form 4 on SEC EDGAR